This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Hemispherx Biopharma, Inc.
Drug Names(s): Interferon alpha-n3 Low Dose Oral
Description: Alferon LDO is a Low Dose Oral formulation of interferon alpha-n3 derived from human leukocytes. Interferons are natural proteins produced by leukocytes, in response to viral pathogens, to combat infection.
Alferon LDO News
Pink Sheet ALFERON LDO ORAL INTERFERON ARC STUDY
Additional information available to subscribers only: